QuadMix Super 001 (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 40mcg/30mg/2mg/0.4mg/mL IN...
FDA Recall #D-0105-2023 — Class II — December 30, 2022
Product Description
QuadMix Super 001 (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 40mcg/30mg/2mg/0.4mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.
Reason for Recall
Lack of Assurance of Sterility
Recalling Firm
Northern VA Compounders PLLC — Sterling, VA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
56 vials
Distribution
Nationwide in the USA
Code Information
Lot#: 11162022@7, Exp 12/31/2022
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated